Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > KingofScotty !!!

<< Previous

Bullboard Posts

Next >>

Post by HighSkies2019on Feb 15, 2021 5:52am

222 Views

Post# 32567173

KingofScotty !!!

Ok KingofScotty .... let's just see what nr comes out ... some of your club members have tried to down this stk sonstantly by saying it was never coming back ....but it sure looks like something in the near future is about to happen .... many many many investors as well as myself anticipate the NR .... call it pumping if you want .... but to make mention of spellchecking another investors post follows your club motto BASH BASH BASH ... glta

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features